| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |